Association of the adaptor TANK with the IκB kinase (IKK) regulator NEMO connects IKK complexes with IKKε and TBK1 kinases by Chariot, Alain et al.
Association of the Adaptor TANK with the IB Kinase (IKK)
Regulator NEMO Connects IKK Complexes with IKK and
TBK1 Kinases*
Received for publication, May 23, 2002, and in revised form, July 16, 2002
Published, JBC Papers in Press, July 19, 2002, DOI 10.1074/jbc.M205069200
Alain Chariot‡§¶, Antonio Leonardi‡¶**, Ju¨rgen Mu¨ller‡, Marianne Bonif§, Keith Brown‡,
and Ulrich Siebenlist‡ ‡‡
From the ‡Laboratory of Immunoregulation, NIAID, National Institutes of Health, Bethesda, Maryland 20892-1876
and the §Laboratory of Medical Chemistry, Center for Cellular and Molecular Therapy, Pathology,
C.H.U. Sart-Tilman, 4000 Lie`ge, Belgium
Canonical activation of NF-B is mediated via phos-
phorylation of the inhibitory IB proteins by the IB
kinase complex (IKK). IKK is composed of a heterodimer
of the catalytic IKK and IKK subunits and a presumed
regulatory protein termed NEMO (NF-B essential mod-
ulator) or IKK. NEMO/IKK is indispensable for activa-
tion of the IKKs in response to many signals, but its
mechanism of action remains unclear. Here we identify
TANK (TRAF family member-associated NF-B activa-
tor) as a NEMO/IKK-interacting protein via yeast two-
hybrid analyses. This interaction is confirmed in mam-
malian cells, and the domains required are mapped.
TANK was previously shown to assist NF-B activation
in a complex with TANK-binding kinase 1 (TBK1) or
IKK, two kinases distantly related to IKK/, but the
underlying mechanisms remained unknown. Here we
show that TBK1 and IKK synergize with TANK to pro-
mote interaction with the IKKs. The TANK binding do-
main within NEMO/IKK is required for proper func-
tioning of this IKK subunit. These results indicate that
TANK can synergize with IKK or TBK1 to link them to
IKK complexes, where the two kinases may modulate
aspects of NF-B activation.
NF-B transcription factors function as critical mediators of
numerous signals during immune, inflammatory, and stress
responses. These factors transcriptionally induce many genes
whose products are critical to drive immune responses in gen-
eral or to fight pathogens directly (1–4). In addition, NF-B is
also directly involved in growth and survival of cells relevant in
stress and immune responses, due to its antiapoptotic and
proliferation-promoting functions (4). A wide variety of extra-
cellular signals initiate signaling cascades that culminate in
the phosphorylation and subsequent proteolytic degradation of
NF-B-inhibitory proteins collectively termed IBs (5). Degra-
dation of the inhibitors liberates the previously bound NF-B
proteins to localize to the nucleus and bind to so-called B DNA
binding elements located within many promoters/enhancers.
The IB inhibitors are phosphorylated on specific serine resi-
dues (5, 6) by kinases residing in a large complex referred to as
the IB kinase complex (IKK).1 IKKs are composed of two
catalytic subunits, IKK and IKK (7–11), as well as a regu-
latory protein, named NEMO (NF-B essential modulator)/
IKK/FIP-3 (12–14). More recently, it has been demonstrated
that the IKK kinases target not only the so-called small IB
inhibitors, of which the IB is the prototype, but that they also
similarly phosphorylate and regulate the p105/NF-B1 and
p100/NF-B2 precursors, leading either to their proteolytic
degradation or to their processing to p50 and p52, respectively
(15–18). In addition to these functions, IKK kinase activity may
also modulate the transactivation potential of the NF-B pro-
teins liberated by the degradation of the inhibitors; activated
IKK kinases have been shown to phosphorylate a transactiva-
tion domain of RelA, thereby promoting its ability to transcrip-
tionally transactivate genes (19).
NEMO/IKK is an essential component of the IKK complex,
as evidenced for example by the inability of many signals,
including TNF and interleukin-1, to induce NF-B activity in
NEMO/IKK-deficient cells (13, 20, 21). It has been suggested
that NEMO/IKK may be required for the correct assembly of
the IKK complex and/or for the recruitment of upstream acti-
vators of the IKK complex (12, 13). However, the functions and
mechanisms of NEMO/IKK remain to be determined. If this
essential component does indeed connect to a variety of differ-
ent upstream signaling mediators, these would be important to
identify, since they may be signal-specific mediators of NF-B
activation and thus more specific potential targets for thera-
pies intended to delimit NF-B activation.
We have used NEMO/IKK as bait in a yeast two-hybrid
screening to identify potential mediators of select upstream
signaling pathways. Previously, we reported on the identifica-
tion of one NEMO/IKK-interacting protein identified in this
way and termed CIKS (connection to IKK and SAPK/JNK) (22)
(also known as Act-1 (23)). Here we describe the identification
of an additional NEMO/IKK-interacting protein, termed
TANK (TRAF family member-associated NF-B activator). We
show that TANK interacts with NEMO/IKK (and the IKKs) in
mammalian cells. TANK had previously been shown to be
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potentially involved in both positive and negative regulation of
NF-B activity (24–26). Positive regulation reportedly occurs
via an association of TANK with two kinases, termed inducible
IB kinase (also known as IKK) and TBK1 (also known as T2K
and NF-B-activating kinase) (27–29), although the mecha-
nisms involved remain unknown. We demonstrate here that
TANK synergizes with IKK and TBK1 to form a complex with
NEMO/IKK and thus with the IKKs. This links IKK and
TBK1 with at least a subset of IKK complexes and suggests
potentially direct effects on IKK-associated functions. We also
provide evidence that the TANK-binding domain of NEMO
may be important in transmitting signals.
EXPERIMENTAL PROCEDURES
Cell Culture and Biological Reagents—Human embryonic kidney 293
and HeLa cells were maintained as described (22, 30). NEMO-deficient
Jurkat cells were a generous gift from Dr. Shao-Cong Sun, (Pennsylva-
nia State University College of Medicine) and were maintained in RPMI
supplemented with 10% fetal bovine serum and 10% penicillin/
streptomycin.
Polyclonal anti-TANK rabbit antibodies were raised against the first
20 and the last 19 amino acids of human TANK. Anti-NEMO/IKK and
anti-Myc antibodies were purchased from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA), as were anti-HA and anti-IKK beads. Anti-
FLAG beads were purchased from Sigma. Monoclonal anti-IKK and
anti-IKK antibodies were from Imgenex (San Diego, CA) and BD
PharMingen (San Diego, CA), respectively. Mouse NEMO/IKK and
human TANK were both cloned by PCR from a mouse or human liver
cDNA library, respectively (CLONTECH, Palo Alto, CA). Truncation
mutants of NEMO/IKK and TANK were generated by PCR. The
FLAG-NEMO TANK construct was made by first cloning a PCR-
generated fragment encompassing the region from amino acid 250 to
the stop codon into pcDNA3.1 FLAG; subsequently, a PCR-generated
fragment harboring amino acids 2–200 was inserted in frame. The
HA-NEMOTANK construct was made by subcloning the
NEMOTANK coding sequence into pcDNA3.1 HA. The FLAG-TANK
IKK construct was made by cloning a PCR-generated fragment en-
coding amino acids 2–110 into pcDNA3.1 FLAG N169-TANK. Full-
length CIKS, NEMO/IKK, IKK, and IKK have been previously
described (22, 30). TBK1 and IKK were PCR-amplified from a liver
cDNA library. cDNAs encoding TANK and IKK were cloned into
pcDNA3.1 FLAG (Invitrogen) for expression in mammalian cells, and
TBK1 and IKK were cloned into pcDNA3.1 Myc. Both TBK1 and IKK
mutant (K38A) constructs were generated by site-directed mutagenesis
(Stratagene, La Jolla, CA). A construct encoding full-length NEMO/
IKK fused to GST was generated by subcloning full-length NEMO/
IKK into pGEX-2T (Amersham Biosciences).
Yeast Two-hybrid Analysis—DNA encoding NEMO/IKK (amino ac-
ids 1–339) was cloned into the GAL4 DNA-binding vector pGBT9
(CLONTECH, Palo Alto, CA) and used as bait in a two-hybrid screen of
a human liver cDNA library (CLONTECH) in Saccharomyces cerevisiae
Y190; positive clones were selected as described (22).
In Vitro Translation and GST Pull-down Assays—In vitro transcrip-
tion and translation were carried out with 1 g of HA-TANK, as de-
scribed (22). Both the full-length GST-NEMO/IKK fusion protein and
the wild type GST were produced and purified as described (22). Pro-
tein-protein interactions were performed by incubating an aliquot of
GST-NEMO/IKK or GST bound to the glutathione-Sepharose beads
with 5 l of in vitro translated HA-TANK as described (31). Beads were
washed five times with 1 ml of phosphate-buffered saline, 1% Triton,
protease inhibitors; resuspended into migrating buffer; and run on an
SDS-polyacrylamide gel before autoradiography.
Immunoprecipitations—For immunoprecipitations involving overex-
pressed proteins, 293 or HeLa cells (3  106) were transfected via
LipofectAMINE (Invitrogen) with expression vectors as indicated in
Figs. 2 (B, C, and D), 3 (B and D), and 4 (B, C, and D). 24 h after
transfection, cells were then washed with phosphate-buffered saline
and lysed in 0.5% Triton lysis buffer. Ectopically expressed proteins
were immunoprecipitated by using anti-FLAG or anti-HA antibodies
bound to agarose beads or by using anti-NEMO antibodies (as indicat-
ed). The immunoprecipitate was washed five times with 0.5% lysis
buffer and subjected to SDS-PAGE.
Immunoprecipitations of endogenous NEMO/IKK or endogenous
IKK were performed with 293 or HeLa cells (6  106) after cells had
been transfected with expression vectors for various proteins as indi-
cated in Figs. 5 and 6B. Harvested cells were washed and lysed as
described above. Anti-NEMO/IKK immunoprecipitations were per-
formed by incubating the total cell extracts with polyclonal antibodies
for 2 h at 4 °C, followed by an overnight incubation with protein A-
agarose conjugate (Santa Cruz Biotechnology) (see Figs. 5, A and C, and
6), whereas anti-IKK immunoprecipitations were performed by incu-
bating the cell extracts with monoclonal anti-IKK beads overnight (see
Fig. 5B).
For identification of ternary complexes by immunoprecipitation ex-
periments (see Figs. 2D and 7 (A and B)), 293 cells (107) were trans-
fected with the indicated expression vectors, as described above. 24 h
after transfection, ectopically expressed TANK was immunoprecipi-
tated with anti-FLAG for 2 h at 4 °C. The immunoprecipitate was
washed five times with the lysis buffer and incubated overnight with
the FLAG peptide (Sigma), according to the protocol provided by the
manufacturer. The supernatants were subsequently incubated with
anti-NEMO antibodies and protein A-agarose conjugate overnight. The
resulting immunoprecipitates were washed with the lysis buffer and
subjected to SDS-PAGE.
For endogenous coimmunoprecipitations, 293 cells (6 107) were left
untreated or were stimulated with 40 ng/ml of PMA and 2 M ionomycin
(Sigma) for the indicated period of time and subsequently lysed in the
lysis buffer. An anti-TANK immunoprecipitation was then performed
with the polyclonal antibodies for 2 h at 4 °C, followed by incubation
overnight with protein A-agarose conjugate. An immunoprecipitation
with an aliquot of a prebleed rabbit serum was performed in parallel as
a negative control. The immunoprecipitates were subjected to anti-
IKK and -IKK Western blots.
Reporter Assay—Jurkat NEMO-deficient cells (6  106) were trans-
fected in 10-cm dishes using the DMRIE-C reagent (Invitrogen) and 5
g of the Ig-B-luciferase reporter (30), with or without 1 g of the
indicated FLAG-NEMO constructs.
RESULTS
Identification of TANK as a NEMO/IKK-interacting Pro-
tein—To gain insights into how NEMO/IKK may transmit
signals to the IKKs, we screened for NEMO/IKK -interacting
proteins via yeast two-hybrid assays. Mouse NEMO/IKK (aa
1–339) was used as bait in a fusion with the DNA binding
domain of GAL4 to trap interacting proteins generated from a
human liver expression library fused to the GAL4 activation
domain. Positive clones isolated included portions of IKK,
IKK, and CIKS (22). In addition, three independent and over-
lapping clones encoded parts of TANK (also known as TRAF-
interacting protein or I-TRAF). TANK had previously been
identified as a potential regulator in NF-B-activating path-
ways, although its precise role is controversial. TANK was
originally discovered as a protein capable of binding to TRAF1,
-2, and -3 (24–26).
To delineate the region in NEMO/IKK that is required for
interaction with TANK, we tested various truncation mutants
of NEMO/IKK (fused to the GAL4 DNA binding domain) for
binding to the isolated TANK-GAL4 activation domain fusion
protein in yeast (Fig. 1B). Among the C-terminal deletion mu-
tants of the 412-amino acid-long NEMO/IKK protein, one
lacking the last 100 amino acids and thus lacking the entire
leucine zipper domain was still able to interact with TANK.
Among the various N-terminal deletions of NEMO/IKK, those
lacking any or all of the first 200 amino acids were still able to
bind TANK, whereas one lacking the first 250 amino acids was
not. Complementing this result, a NEMO/IKK construct com-
posed of amino acids 150–250 was sufficient to mediate the
interaction with TANK. Based on these findings, we conclude
that the region between amino acids 200 and 250 of NEMO/
IKK mediates binding to TANK. This domain of NEMO/IKK
is distinct from the one required for interaction with the IKKs
(amino acids 50–100) (32, 33).2 The interaction between
NEMO/IKK and TANK was also confirmed in vitro. An Esch-
erichia coli-produced recombinant GST-NEMO/IKK fusion
protein (full-length) bound in vitro translated [35S]HA-TANK,
2 A. Leonardi and U. Siebenlist, unpublished data.
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whereas recombinant GST alone did not (Fig. 2A, top panel).
Next we investigated the interaction of NEMO/IKK with
TANK in mammalian cells. FLAG-TANK was transiently co-
expressed in 293 cells together with HA-NEMO/IKK or a
NEMO/IKK mutant lacking the first 250 amino acids (HA-
NEMO/IKK N250). Cell extracts were immunoprecipitated
with anti-FLAG antibodies (Fig. 2B, top panel) and HA-NEMO/
IKK was co-immunoprecipitated, but only if FLAG-TANK had
also been co-transfected (lane 5). The specificity of the interac-
tion between NEMO/IKK and TANK was confirmed by the
fact that the NEMO/IKK deletion mutant lacking the first 250
amino acids (HA-NEMO/IKK N250) was not co-immunopre-
cipitated with TANK (lane 6), in agreement with the data in
yeast. Similar results were obtained when the NEMO/IKK
was immunoprecipitated to look for TANK (data not shown).
Note that when both NEMO/IKK and TANK were co-ex-
pressed, a shift in the migration of the TANK protein was
detected by Western blot, even in the absence of any overex-
pressed kinases (middle panel, lane 5). To further confirm the
interaction between TANK and NEMO/IKK, 293 cells were
transfected with both HA-NEMO/IKK and FLAG-TANK, and
extracts were immunoprecipitated with anti-HA (Fig. 2C).
TANK was co-immunoprecipitated with NEMO/IKK (Fig. 2C,
top panel, lane 2). A shift in the TANK protein was detected
when co-expressed with NEMO/IKK (Fig. 2C, middle panel;
lane 2, FLAG-TANK*), most likely due to phosphorylation.
Interestingly, it is this slower migrating form of TANK that
preferentially co-immunoprecipitated with HA-NEMO/IKK
(Fig. 2C, top panel, lane 2).
Because FLAG-TANK could also be shown to co-immunopre-
cipitate with HA-IKK, especially if NEMO/IKK was cotrans-
fected (data not shown), we asked whether these three proteins
might be able to form a ternary complex. To test this, 293 cells
were transfected either with HA-IKK or with FLAG-TANK or
both (Fig. 2D). Anti-FLAG immunoprecipitations were carried
out, and the immunoprecipitates were released from the beads
by incubating them with a FLAG peptide. The released mate-
rial was immunoprecipitated with antibodies to the endoge-
nous NEMO/IKK and an anti-HA Western analysis was per-
formed, revealing the presence of IKK (lane 2). Therefore, a
ternary complex of TANK, NEMO/IKK, and IKK must have
been formed in 293 cells. Importantly, this complex was formed
with endogenous NEMO/IKK, demonstrating that endoge-
nous levels of NEMO/IKK were sufficient to mediate the in-
teraction between transfected TANK and IKK.
Two Distinct Regions of TANK Are Required for Interaction
with NEMO/IKK—To delineate the domain in TANK required
for interaction with NEMO/IKK in mammalian cells, various
truncated TANK proteins were generated (Fig. 3, A and C) and
tested for their ability to co-immunoprecipitate with NEMO/
IKK in 293 cells (Fig. 3, B and D). A TANK protein lacking the
first N-terminal 30 aa (Fig. 3A) was able to co-immunoprecipi-
tate with NEMO/IKK (Fig. 3B, lane 7), but TANK proteins
lacking the first N-terminal 70 aa or more were not (lanes 3–5,
8, and 9). All C-terminal deletions of TANK tested (Fig. 3C)
failed to co-immunoprecipitate with NEMO/IKK (Fig. 3D,
lanes 3–8). This suggests that an N-terminal TANK domain
(between aa 30 and 70) and a C-terminal TANK domain (be-
tween aa 248 and 425) are both required for interaction with
the regulatory subunit of the IKK complex in mammalian cells.
(The same results were obtained with a NEMO/IKK construct
lacking the C-terminal 72 aa; data not shown). By contrast, the
C-terminal domain of TANK was sufficient in yeast (see Fig.
1A). The reason for this is not clear, but the assay for the
interaction in yeast may be more sensitive than the one in
mammalian cells.
TANK Binding-deficient NEMO/IKK Mutant Impaired in
Mediating PMA and Ionomycin (P/I)-induced NF-B Activa-
tion—We next explored the possible relevance of the interac-
tion of TANK with NEMO/IKK in mediating activation of
NF-B. A NEMO/IKK mutant was constructed in which
the TANK-binding domain was specifically deleted
(NEMOTANK) (Fig. 4A). When overexpressed in 293 cells,
this NEMO mutant failed to interact with TANK (Fig. 4B, top
panel, lane 6), as predicted by the results obtained in yeast (see
Fig. 1B). However, this NEMO mutant still interacted with
transfected IKK (Fig. 4C, top panel, lane 3). Moreover,
NEMOTANK also interacted with CIKS, another NEMO/
FIG. 1. NEMO/IKK and TANK interact in yeast. A, schematic representation of the human TANK protein and of the three products encoded
by the clones isolated by yeast two-hybrid screening. The TRAF interaction domain (aa 170–191) is highlighted. B, mapping of the TANK
interaction domain on NEMO/IKK by yeast two-hybrid experiments. The various NEMO/IKK constructs, cloned in frame with the GAL4 DNA
binding domain of the pGBT9 vector, are schematically represented. The leucine zipper domain (from aa 311 to 339) of NEMO/IKK is marked.
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IKK-interacting protein (22) (Fig. 4D, top panel, lane 3).
NEMO/IKK thus interacts with TANK via a domain not re-
quired for interaction of NEMO/IKK with the IKKs or with
CIKS. We then tested the ability of the NEMOTANK mutant
to restore NF-B activation in NEMO-deficient Jurkat cells
(34) in response to stimulation with P/I. Whereas transfection
of wild-type NEMO/IKK led to significant P/I-induced B re-
porter activity, the NEMOTANK mutant was largely unable
to transmit this signal (Fig. 4E). Although this does not prove
that interaction with TANK is critical for the function of
NEMO, given that as yet unknown functions of NEMO may
have been impaired in this particular mutant, the data are
nonetheless consistent with the notion that NEMO/IKK nor-
mally has to bind to proteins such as TANK to be fully
functional.
IKK and TBK1 Promote the Interaction of TANK with the
IKK Complex—Two reports identified murine inducible IB
kinase (35) (human homolog termed IKK (36)) and TBK1 (also
named NF-B-activating kinase (28) and T2K (37)) as two
TANK-interacting kinases (27, 35) capable of activating NF-B
in transfection experiments. Inducible IB kinase and TBK1
were shown to interact with the N-terminal half of TANK and
to cause TANK phosphorylation in cotransfection experiments
in the C-terminal half (27, 35). Nevertheless, mechanisms for
activation of NF-B by these kinases remained uncertain. We
confirmed and extended the published work on the interaction
and phosphorylation of TANK with IKK and TBK1. Both
kinases interacted with TANK in the region between amino
acids 111 and 169 (just C-terminal to the first of two domains
required for interaction with NEMO/IKK), and they phospho-
rylated TANK between amino acids 192 and 247, dependent on
the interaction (data not shown).
To investigate whether IKK may be involved in regulating
the ability of TANK to interact with NEMO/IKK, 293 cells
were transfected with Myc-tagged IKK (Fig. 5A, lane 1) or
FLAG-TANK (lane 2) or combinations of both, using either wild
type (lane 3) or a K38A kinase-dead (DN) mutant of IKK (lane
4). Endogenous NEMO/IKK was immunoprecipitated, and the
resulting immunoprecipitates were subjected to anti-FLAG
and anti-Myc Western analysis (top two panels). Exogenously
introduced IKK could not be co-immunoprecipitated with en-
dogenous NEMO/IKK (lane 1, second panel from top), as pre-
viously demonstrated (36), whereas FLAG-TANK was detecta-
ble only after prolonged exposure (lane 2, top panel; prolonged
exposure not shown). However, co-expression of transfected
wild type IKK strongly promoted the interaction between
TANK and NEMO/IKK  (lane 3, top panel). Similarly, co-
expression of transfected TANK resulted in a readily detectable
co-immunoprecipitation of IKK and NEMO/IKK (lane 3, sec-
ond panel from top). Interestingly, the K38A IKK mutant also
promoted the interaction between TANK and NEMO/IKK,
albeit it to a lesser degree, suggesting that the kinase activity
of IKK is not absolutely required for this effect (lane 4, top two
panels).
An analogous experiment was performed in which endoge-
nous IKK was immunoprecipitated instead of endogenous
NEMO/IKK (Fig. 5B). As expected, little of the exogenously
introduced TANK was found in association with IKK in the
absence of transfected IKK, but the presence of IKK strongly
promoted the interaction of TANK with IKK, presumably via
NEMO/IKK (top panel, lanes 2 and 3, respectively). Again,
this effect of IKK was largely independent of its kinase activ-
ity (lane 4). Taken together, the results suggest that TANK can
link IKK to the IKK complex and that TANK and IKK syn-
ergize to promote this interaction, largely independent of IKK
kinase activity.
We obtained similar results when TBK1 was tested in these
types of experiments. As with IKK, exogenously introduced
TBK1 could be readily found in association with endogenous
NEMO/IKK, but only in the presence of exogenously intro-
duced TANK (Fig. 5C, lane 3).
Given that IKK (and TBK1) promote the association of
TANK with the IKKs, although they do not interact with the
IKKs by themselves, we tested whether or not a TANK con-
struct lacking the IKK-interacting domain (FLAG-TANK
IKK; Fig. 6A) could still be promoted by IKK to coimmuno-
precipitate with NEMO/IKK. We first demonstrated with
transfection experiments in 293 cells that such a mutant of
TANK indeed failed to interact with IKK and failed to be
phosphorylated by IKK in an in vitro kinase assay but contin-
ued to co-immunoprecipitate well with co-transfected NEMO/
IKK and IKK, as predicted (data not shown). Such a mutant
allowed us to ask whether IKK promoted the association of
TANK with NEMO/IKK by a direct association with TANK or
FIG. 2. TANK interacts with NEMO/IKK and the IKK complex.
A, in vitro protein-protein interaction between HA-TANK and GST-
NEMO/IKK. Top panel, lane 1, 0.5 l of in vitro translated HA-TANK;
lane 2 and 3, 5 l of in vitro translated HA-TANK was used in “pull-
down” experiments with GST-NEMO/IKK or wild type GST (negative
control), respectively. Bottom panel, GST-NEMO/IKK (lane 1) and
wild type GST (lane 2) visualized on a polyacrylamide gel stained by
Coomassie Blue. B and C, coimmunoprecipitation of FLAG-TANK and
HA-NEMO/IKK in mammalian cells. 293 cells were transfected with
the indicated expression vectors and lysed in 0.5% Triton lysis buffer.
Total extracts were immunoprecipitated with anti-FLAG (B) or anti-HA
(C) antibodies, followed by Western analysis with anti-HA or anti-
FLAG antibodies (upper panels) (B and C, respectively). The presence of
FLAG-TANK, HA-NEMO/IKK, and HA-N250 NEMO/IKK in the
extracts is demonstrated with Western analyses in the middle and
lower panels, respectively. See “Results” for FLAG-TANK*. D, evidence
for a ternary complex of FLAG-TANK, HA-IKK, and endogenous
NEMO/IKK. 293 cells were transfected with HA-IKK (lane 1) or
FLAG-TANK (lane 3) or both (lane 2). Cells were harvested 24 h later,
and extracts were subjected to an anti-FLAG immunoprecipitation.
After extensive washes, the FLAG immunoprecipitates were released
from the beads by incubating them with a FLAG peptide overnight.
Then a second immunoprecipitation was performed with anti-NEMO/
IKK antibodies, followed by an anti-HA Western analysis to
detect HA-IKK (top panel). The bottom three panels show Western
analyses for HA-IKK, FLAG-TANK, and endogenous NEMO. IP,
immunoprecipitation.
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whether this might occur indirectly via an effect of IKK on the
IKK complex. As shown in Fig. 6B (lane 5), the TANK mutant
lacking the IKK binding domain was also no longer promoted
by this kinase to interact with endogenous NEMO/IKK,
whereas wild-type TANK was, regardless of whether IKK was
wild-type or kinase-inactive (Fig. 6B, lanes 2 and 3, respective-
ly). These results suggest that the direct association of IKK
with TANK allows these proteins to cooperatively interact with
NEMO/IKK. It is possible, for example, that binding of IKK
changes the conformation of TANK such that it more readily
interacts with the IKK complex.
The results also suggest that TANK might be part of a
ternary complex with both IKK and NEMO/IKK  (and thus
the IKK complex). To test such a hypothesis directly, we trans-
fected 293 cells with FLAG-tagged TANK and either wild-type
(WT) or K38A mutant (DN) Myc-tagged IKK (Fig. 7A, lanes 2
and 3, respectively). An anti-FLAG immunoprecipitation was
carried out, followed by incubation with a FLAG peptide to
elute the immunoprecipitated material so that it could be re-
immunoprecipitated with antibodies to endogenous NEMO/
IKK. These final immunoprecipitates were subjected to an
anti-Myc Western analysis. In such experiments, we detected
both WT IKK and the K38A (DN) mutant (upper panel, lanes
2 and 3, respectively), indicative of the existence of a ternary
complex that includes TANK, IKK, and endogenous NEMO/
IKK. The same results were obtained in a similar experiment
in which endogenous IKK was immunoprecipitated instead of
endogenous NEMO/IKK (Fig. 7B). These experiments suggest
that ectopically expressed IKK can be part of a ternary com-
plex with TANK and the IKK complex.
Endogenous TANK Associates with Endogenous IKK, Inde-
pendent of P/I—IKK has been described as part of a PMA-
inducible IKK-like complex that contains an unknown IKK-
like kinase activity (36). We therefore investigated whether
stimulation of 293 cells with P/I could modulate the ability of
TANK to interact with IKK or with IKK, a representative
component of the IKK complex (Fig. 8). 293 cells were either
left unstimulated or were treated from 15 min to 8 h with P/I
prior to harvest, and total cell extracts were subjected to an
anti-TANK immunoprecipitation, followed by an anti-IKK
or anti-IKK Western analysis. As expected, we detected a
strong coimmunoprecipitation between endogenous TANK
and endogenous IKK, but this association was not modu-
lated by the P/I treatment (second panel from top, lanes 2–7).
We also observed a much weaker but very reproducible asso-
ciation of endogenous TANK with endogenous IKK (top
FIG. 3. Mapping of the NEMO/IKK-interacting sites on TANK. A and C, schematic illustration of the TANK expression constructs tested
for interaction with NEMO/IKK. B and D, coimmunoprecipitations of FLAG-TANK, FLAG-N TANK truncations (B), and FLAG-C TANK
truncations (D) with HA-NEMO/IKK. 293 cells were transfected with the indicated expression vector. Total extracts were immunoprecipitated
with anti-FLAG antibodies (TANK) followed by Western analyses with anti-HA (NEMO) antibodies (top panels). The presence of HA-NEMO/IKK
and the various TANK truncation mutants are demonstrated with Western analyses in the middle and bottom panels. B (lanes 2 and 6) and D (lane
2) contain full-length FLAG-TANK; the remaining lanes contain TANK mutants as indicated.
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panel; overnight exposure; IKK was detected within min-
utes). Again, the association of TANK with the IKK complex
(as demonstrated for IKK) was not modulated by the P/I
stimulation (top panel, lanes 2–7). These results suggest that
P/I treatment, which was hypothesized to activate IKK has
apparently no effect on the ability of TANK to associate with
FIG. 4. NEMO/IKK lacking the TANK-interacting site does not fully recapitulate NF-B activation in NEMO-deficient Jurkat
cells. A, schematic representation of the full-length NEMO/IKK and NEMOTANK constructs. B, NEMOTANK does not interact with TANK.
293 cells were transfected with the indicated plasmids and lysed in 0.5% Triton lysis buffer. Total extracts were immunoprecipitated with
anti-FLAG antibodies (TANK), followed by Western analysis with anti-HA (NEMO) (top panel). The presence of FLAG-TANK or of HA-NEMO/
IKK or HA-NEMOTANK in the extracts is shown in the middle or lower panels, respectively. IP, immunoprecipitation. C and D, NEMO/IKK
interacts with IKK (C), CIKS (D), and TANK through distinct domains. 293 cells were transfected with the indicated expression vectors and lysed.
Total extracts were immunoprecipitated with anti-FLAG antibodies (NEMO (C) or CIKS (D)), followed by Western analysis with anti-HA (IKK
(C) or NEMO and NEMOTANK (D)) (top panels). The presence of HA-IKK or of FLAG-NEMO/IKK or NEMOTANK (C) and of FLAG-CIKS
or of HA-NEMO/IKK or NEMOTANK (D) in the extracts is shown with Western analysis in the middle and bottom panels. E, reconstitution of
NEMO-deficient Jurkat cells with FLAG-NEMO/IKK or FLAG-NEMOTANK: NF-B reporter activity in response to P/I treatment. Shown is the
-fold induction of luciferase activity over the basal activity observed with 5 g of the Ig-B reporter plasmid alone. Shown are the results of a
representative experiment performed in triplicate, after normalization with -galactosidase activities (mean values  S.D.). Similar results were
obtained in two additional independent experiments.
FIG. 5. IKK and TBK1 promote the interaction of TANK with the IKK complex. 293 cells were transfected with FLAG-TANK (lanes 2)
or with wild type IKK (WT) (A and B; lanes 1) or with wild-type TBK1 (C; lane 1) or with both FLAG-TANK and wild type IKK or K38A (DN)
dominant negative version of IKK (A and B; lanes 3 and 4, respectively) or with both FLAG-TANK and wild-type or DN TBK1 (C; lanes 3 and 4,
respectively). Total cell extracts were immunoprecipitated with antibodies to endogenous NEMO (A and C) or antibodies to endogenous IKK (B).
TANK (A and B; top panels) and IKK kinases (A and C; second or top panel), respectively, were then detected in these immunoprecipitates by
Western analyses with anti-FLAG or anti-Myc antibodies, as shown (in A, second panel from top, as stripped and reprobed to yield top panel). Total
cell extracts were also subjected to Western analyses with anti-NEMO/IKK, anti-FLAG, anti-Myc, and anti-IKK antibodies, as indicated (bottom
three panels).
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IKK or to associate with the IKK complex. This is at least
consistent with results above that demonstrated that the
kinase activity of IKK is not required for association with
the IKK complex via TANK.
DISCUSSION
We have shown here with experiments in yeast, in vitro and
in transfected cells, that TANK can physically associate with
NEMO/IKK and thus the IKK complex. Two domains of
TANK are required for the interaction with an N-terminal
domain of NEMO/IKK in mammalian cells. An association of
TANK with IKK complexes could also be demonstrated in un-
transfected cells. Although TANK has been previously impli-
cated in regulation of NF-B activity, a direct link to NEMO/
IKK or to the IKK complex has not been reported. This
discovery supports the previously suggested notion that
NEMO/IKK serves an adapter function to link upstream sig-
nal mediators with the IKK complex (12). In addition to TANK,
other proteins such as the previously identified CIKS (22) (also
known as Act1) may also interact with NEMO/IKK to link
IKKs to select upstream signaling pathways. Some IKKs may
be dedicated to specific signaling pathways.
Transfected TANK was reported to negatively affect activa-
tion of NF-B in response to various stimuli (25, 26). The
mechanisms for this negative effect remain to be determined,
although it was suggested that for some signals, TANK could
inhibit by competing with members of the TNF receptor family
for binding to TRAF2 (26). Transfected TANK was also re-
ported to positively regulate activation of NF-B together with
low levels of co-transfected TRAF2 (24). This effect was subse-
quently described to be mediated by the association of TANK
with kinases distantly related to IKK/, namely TBK1 and
IKK (27, 35). However, what signals these kinases respond to
and by what mechanism they may activate NF-B in concert
with TANK has remained unclear. We have shown here that
the association of TANK with NEMO/IKK and the IKK com-
plex is dramatically increased in the presence of transfected
IKK or TBK1. The physical interaction of IKK and TBK1
with TANK is sufficient to promote the interaction of TANK
with NEMO/IKK, whereas their kinase activities are largely
dispensable for this effect. IKK was previously also reported to
associate with and regulate an as yet unidentified IKK-like
kinase (35). Whereas the present data do not address this
issue, they do demonstrate an association of IKK with the
classical IKK kinases, which could of course occur in addition to
the association with an unknown IKK-like activity. Our data
suggest that TANK may function as an adapter to mediate a
direct influence of IKK and TBK1 on the IKK core complex or
on other proteins directly associated with the core IKK com-
plex. We speculate that at least a subset of IKK core complexes
exist as part of more loosely assembled, larger signaling com-
plexes that may serve to channel specific activation signals,
possibly at special sites within cells. As part of such larger
signaling complexes surrounding some IKK cores, TBK1 and
IKK could be in a position not only to directly modulate the
IKK/ kinase activity (27) but conceivably also to regulate
FIG. 6. IKK-promoted interaction of TANK with NEMO/IKK
depends on the ability of TANK to interact with IKK. A, sche-
matic representation of both the wild type TANK protein and the TANK
construct wherein the IKK interacting domain has been specifically
deleted (TANK IKK). B, IKK does not promote the interaction of
TANK IKK with endogenous NEMO/IKK. 293 cells were transfected
with FLAG-TANK (lane 1) or FLAG-TANK IKK (lane 4) or with
FLAG-TANK and Myc-tagged IKK WT or K38A (lanes 2 and 3, respec-
tively) or with FLAG-TANK IKK and Myc-tagged IKK; lane 5). An
anti-NEMO/IKK immunoprecipitation was performed followed by
Western analysis with anti-FLAG antibodies (top panel). The anti-
FLAG and anti-Myc Western analyses are shown in the bottom two
panels.
FIG. 7. Evidence for a ternary complex of transfected TANK,
wild type IKK or K38A mutant IKK and endogenous NEMO/
IKK (A) or endogenous IKK- (B). A and B, 293 cells were trans-
fected with either Myc-tagged IKK (lane 1) or FLAG-TANK (lane 4) or
with both FLAG-TANK and Myc-tagged IKK wild type (lane 2) or
K38A (DN) (lane 3). Total lysates were immunoprecipitated with anti-
FLAG antibodies, and after elution the material was immunoprecipi-
tated with anti-NEMO or anti-IKK antibodies. Western analyses on
final immunoprecipitates were performed with anti-Myc antibodies (top
panels). Western analyses of total extracts with anti-Myc, anti-FLAG,
anti-NEMO/IKK, and anti-IKK antibodies are shown in the bottom
three panels.
FIG. 8. Interaction of endogenous TANK with endogenous
IKK and with endogenous IKK is not modulated by PMA/
ionomycin (P/I) treatment. 293 cells were left unstimulated or
treated with P/I from 15 min to 8 h. An anti-TANK immunoprecipita-
tion was performed followed by Western analyses with anti-IKK (top
panel, lanes 2–7; overnight exposure shown) or anti-IKK (second panel
from top, lanes 2–7; the anti-IKK blot was stripped and reprobed with
only a few minutes of exposure). An immunoprecipitation using an
aliquot of a prebleed rabbit serum was also performed as a negative
control (lane 1). Western analyses for the relevant proteins in total
extracts are shown in the lower panels.
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other aspects, such as association of the IKK/ kinases with
their substrates or the phosphorylation of NF-B proteins.
In attempts to find a functional requirement for the associ-
ation of TANK with NEMO/IKK, we discovered a possible role
in mediating activation of NF-B via P/I. NEMO-deficient
Jurkat cells reconstituted with a NEMO mutant lacking the
TANK-interacting site (but able to bind CIKS and IKK/) are
significantly impaired in P/I-induced activation of NF-B as
compared with NEMO-deficient Jurkat cells reconstituted with
wild-type NEMO. This suggests that TANK or another protein
binding NEMO in the same domain may be required for NEMO
to properly channel signals to the IKKs, although alternative
explanations cannot be ruled out as yet.
An association of TBK1 or IKK with the IKK complex could
affect NF-B activity in several ways. In addition to the possi-
bility that TBK1 and IKK activate the IKKs (28), the associ-
ation with the IKK complex could also help these kinases
modulate other functions, such as the transactivation potential
of NF-B proteins. Such a hypothesis can be derived from
T2K-deficient mice. T2K-deficient embryos succumbed to mas-
sive apoptosis in the liver, similar to IKK and RelA-deficient
mice (38–41). In the two latter knockouts, the defect was
shown to be due lack of activation of NF-B in response to TNF,
which led to TNF-induced apoptosis, unopposed by the nor-
mally protective effects of NF-B. In T2K-deficient embryonic
cells, however, inflammatory cytokine-induced liberation of
NF-B from their IB inhibitors was shown to be largely intact,
and some NF-B target genes were induced, whereas others
were not. Therefore, it was speculated that promoter-specific
transactivation functions of liberated NF-B proteins might be
targeted by TBK1. Given the ready access TBK1 and IKK
could have to NF-B dimers via their association with TANK
and the IKK complex (as shown here), these two kinases could
well be in position to modulate transactivation functions of
NF-B proteins such as RelA.
In summary, our data provide direct evidence that at least
some IKK core complexes can be linked to TANK or other
potentially similarly acting proteins. TANK may function as an
adapter for the IKK and TBK1 kinases. These kinases could
be liberated and activated by as yet unknown signals so that
they may, together with TANK, synergistically engage the
IKKs to form a ternary complex. As part of such a hypothesized
larger IKK complexes, IKK and TBK1 could directly modulate
activities of the IKK complex. TANK and CIKS may belong to
a larger family of adaptors dedicated to link specific signaling
pathways to IKK complexes.
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